Citations (67)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Matthew Herder. (2013) When Everyone Is an Orphan: Against Adopting a U.S.-Styled Orphan Drug Policy in Canada. Accountability in Research 20:4, pages 227-269.
Read now
Read now
Jason S Rotter, Douglas Foerster & John FP Bridges. (2012) The changing role of economic evaluation in valuing medical technologies. Expert Review of Pharmacoeconomics & Outcomes Research 12:6, pages 711-723.
Read now
Read now
Articles from other publishers (65)
Maria Dimitrova, Ivett Jakab, Zornitsa Mitkova, Maria Kamusheva, Konstantin Tachkov, Bertalan Nemeth, Antal Zemplenyi, Dalia Dawoud, Diana M. J. Delnoij, François Houýez & Zoltan Kalo. (2022) Potential Barriers of Patient Involvement in Health Technology Assessment in Central and Eastern European Countries. Frontiers in Public Health 10.
Crossref
Crossref
Rachel R J Kalf, Diana M J Delnoij, Bettina Ryll, Marcel L Bouvy & Wim G Goettsch. (2021) Information Patients With Melanoma Spontaneously Report About Health-Related Quality of Life on Web-Based Forums: Case Study. Journal of Medical Internet Research 23:12, pages e27497.
Crossref
Crossref
Viviane Karoline da Silva Carvalho, Everton Nunes da Silva & Jorge Otávio Maia Barreto. (2021) Public engagement in health technology assessment in Brazil: the case of the public consultation on National Clinical Guidelines for Care in Normal Birth. BMC Public Health 21:1.
Crossref
Crossref
C. Georgieva & A. Yanakieva. (2021) Role of the Patient‘s Viewpoint in Health Technologies Assessment in Bulgaria. Acta Medica Bulgarica 48:3, pages 5-11.
Crossref
Crossref
Katherine Boothe. (2021) (Re)defining legitimacy in Canadian drug assessment policy? Comparing ideas over time. Health Economics, Policy and Law 16:4, pages 424-439.
Crossref
Crossref
Katherine Chinchilla, Cristiano Matos, Victoria Hall & Florence van Hunsel. (2020) Patient Organizations’ Barriers in Pharmacovigilance and Strategies to Stimulate Their Participation. Drug Safety 44:2, pages 181-191.
Crossref
Crossref
Cedric Gesbert, Joëlle André-Vert, Marc Guerrier, Margaret Galbraith, Christine Devaud, Jean-Claude K. Dupont & Marie-France Mamzer. (2021) The contribution of French patient and consumer groups to health technology assessments over a 2-year period: an observational retrospective study. International Journal of Technology Assessment in Health Care 37:1.
Crossref
Crossref
Julia Bidonde, Meredith Vanstone, Lisa Schwartz & Julia Abelson. (2021) An institutional ethnographic analysis of public and patient engagement activities at a national health technology assessment agency. International Journal of Technology Assessment in Health Care 37:1.
Crossref
Crossref
Hossein Haji Ali Afzali, Jackie Street, Tracy Merlin & Jonathan Karnon. (2021) The representation of public values in health technology assessment to inform funding decisions: the case of Australia's national funding bodies. International Journal of Technology Assessment in Health Care 37:1.
Crossref
Crossref
Heidi Livingstone, Vassilia Verdiel, Helen Crosbie, Sheela Upadhyaya, Kevin Harris & Lizzie Thomas. (2021) Evaluation of the impact of patient input in health technology assessments at NICE. International Journal of Technology Assessment in Health Care 37:1.
Crossref
Crossref
Edilene Lopes, Jackie Street, Tania Stafinski, Tracy Merlin & Drew Carter. (2020) The rationale and design of public involvement in health-funding decision making: focus groups with the Canadian public. International Journal of Technology Assessment in Health Care 36:6, pages 592-598.
Crossref
Crossref
Chiara Whichello, Karin Schölin Bywall, Jonathan Mauer, Watt Stephen, Irina Cleemput, Cathy Anne Pinto, Eline van Overbeeke, Isabelle Huys, Esther W. de Bekker-Grob, Richard Hermann & Jorien Veldwijk. (2020) An overview of critical decision-points in the medical product lifecycle: Where to include patient preference information in the decision-making process?. Health Policy 124:12, pages 1325-1332.
Crossref
Crossref
Matteo Garavaglia, Ali Gökhan Demir, Stefano Zarini, Brian M. Victor & Barbara Previtali. (2020) Fiber laser welding of AA 5754 in the double lap-joint configuration: process development, mechanical characterization, and monitoring. The International Journal of Advanced Manufacturing Technology 111:5-6, pages 1643-1657.
Crossref
Crossref
Shai Mulinari, Andreas Vilhelmsson, Emily Rickard & Piotr Ozieranski. (2020) Five years of pharmaceutical industry funding of patient organisations in Sweden: Cross-sectional study of companies, patient organisations and drugs. PLOS ONE 15:6, pages e0235021.
Crossref
Crossref
Eugena Stamuli, Gerry Richardson, Michael Robling, Michelle Edwards, David J. Torgerson, Kerry Hood, Julia Sanders & Sarah Ronaldson. (2020) A Discrete-Choice Experiment to capture public preferences on the benefits of home-visiting programme for teenage mothers. F1000Research 9, pages 677.
Crossref
Crossref
Olga Löblová, Trayan Trayanov, Marcell Csanádi & Piotr Ozierański. (2020) The Emerging Social Science Literature on Health Technology Assessment: A Narrative Review. Value in Health 23:1, pages 3-9.
Crossref
Crossref
Rosanne Janssens, Isabelle Huys, Eline van Overbeeke, Chiara Whichello, Sarah Harding, Jürgen Kübler, Juhaeri Juhaeri, Antonio Ciaglia, Steven Simoens, Hilde Stevens, Meredith Smith, Bennett Levitan, Irina Cleemput, Esther de Bekker-Grob & Jorien Veldwijk. (2019) Opportunities and challenges for the inclusion of patient preferences in the medical product life cycle: a systematic review. BMC Medical Informatics and Decision Making 19:1.
Crossref
Crossref
Katherine Boothe. (2019) “Getting to the Table”: Changing Ideas about Public and Patient Involvement in Canadian Drug Assessment. Journal of Health Politics, Policy and Law 44:4, pages 631-663.
Crossref
Crossref
Doreen Tembo, Elizabeth Morrow, Louise Worswick & Debby Lennard. (2019) Is Co-production Just a Pipe Dream for Applied Health Research Commissioning? An Exploratory Literature Review. Frontiers in Sociology 4.
Crossref
Crossref
Piet L.C.M. van Riel, Rixt M. Zuidema, Carine Vogel & Sanne A.A. Rongen-van Dartel. (2019) Patient Self-Management and Tracking. Rheumatic Disease Clinics of North America 45:2, pages 187-195.
Crossref
Crossref
Maggie MacNeil, Melissa Koch, Ayse Kuspinar, Don Juzwishin, Pascale Lehoux & Paul Stolee. (2019) Enabling health technology innovation in Canada: Barriers and facilitators in policy and regulatory processes. Health Policy 123:2, pages 203-214.
Crossref
Crossref
Kate L Mandeville, Rosie Barker, Alice Packham, Charlotte Sowerby, Kielan Yarrow & Hannah Patrick. (2019) Financial interests of patient organisations contributing to technology assessment at England’s National Institute for Health and Care Excellence: policy review. BMJ, pages k5300.
Crossref
Crossref
Ana Toledo-Chávarri, Yolanda Alvarez-Perez, Yolanda Triñanes, Lilisbeth Perestelo-Pérez, Mireia Espallargues, Matilde Palma & Pedro Serrano-Aguilar. (2019) Toward a Strategy to Involve Patients in Health Technology Assessment in Spain. International Journal of Technology Assessment in Health Care 35:2, pages 92-98.
Crossref
Crossref
Eline van Overbeeke, Chiara Whichello, Rosanne Janssens, Jorien Veldwijk, Irina Cleemput, Steven Simoens, Juhaeri Juhaeri, Bennett Levitan, Jürgen Kübler, Esther de Bekker-Grob & Isabelle Huys. (2019) Factors and situations influencing the value of patient preference studies along the medical product lifecycle: a literature review. Drug Discovery Today 24:1, pages 57-68.
Crossref
Crossref
Hassane Alami, Marie-Pierre Gagnon & Jean-Paul Fortin. (2018) Involving Citizen-Patients in the Development of Telehealth Services: Qualitative Study of Experts’ and Citizen-Patients’ Perspectives. Journal of Participatory Medicine 10:4, pages e10665.
Crossref
Crossref
Kyriakos Souliotis, Lily E. Peppou, Eirini Agapidaki & Chara Tzavara. (2018) Health Democracy Index: Development and Validation of a Self-Reported Instrument for Measuring Patient Participation in Health Policy. Frontiers in Public Health 6.
Crossref
Crossref
Claudio Jommi & Arianna Bertolani. (2018) Patients’ Associations and HTA for medicines: actual and future role in Italy. Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish 2018, pages 228424031877096.
Crossref
Crossref
Anna Mae Scott & Janet L. Wale. (2017) Patient advocate perspectives on involvement in HTA: an international snapshot. Research Involvement and Engagement 3:1.
Crossref
Crossref
Axel C. Mühlbacher & F. Reed Johnson. (2017) Giving Patients a Meaningful Voice in European Health Technology Assessments: The Role of Health Preference Research. The Patient - Patient-Centered Outcomes Research 10:4, pages 527-530.
Crossref
Crossref
Mickaël Hiligsmann, Benedict G. Dellaert, Carmen D. Dirksen, Verity Watson, Sandrine Bours, Stefan Goemaere, Jean-Yves Reginster, Christian Roux, Bernie McGowan, Carmel Silke, Bryan Whelan, Adolfo Diez-Perez, Elisa Torres, Georgios Papadakis, Rene Rizzoli, Cyrus Cooper, Gill Pearson & Annelies Boonen. (2017) Patients’ preferences for anti-osteoporosis drug treatment: a cross-European discrete choice experiment. Rheumatology 56:7, pages 1167-1176.
Crossref
Crossref
Rob Baltussen, Maarten Paul Maria Jansen, Leon Bijlmakers, Janneke Grutters, Anouck Kluytmans, Rob P. Reuzel, Marcia Tummers & Gert Jan van der Wilt. (2017) Value Assessment Frameworks for HTA Agencies: The Organization of Evidence-Informed Deliberative Processes. Value in Health 20:2, pages 256-260.
Crossref
Crossref
Celso P. Pagatpatan & Paul R. Ward. (2017) Understanding the factors that make public participation effective in health policy and planning: a realist synthesis. Australian Journal of Primary Health 23:6, pages 516.
Crossref
Crossref
Laura Weeks, Julie Polisena, Anna Mae Scott, Anke-Peggy Holtorf, Sophie Staniszewska & Karen Facey. (2017) EVALUATION OF PATIENT AND PUBLIC INVOLVEMENT INITIATIVES IN HEALTH TECHNOLOGY ASSESSMENT: A SURVEY OF INTERNATIONAL AGENCIES. International Journal of Technology Assessment in Health Care 33:6, pages 715-723.
Crossref
Crossref
Karen M. Facey. 2017. Patient Involvement in Health Technology Assessment. Patient Involvement in Health Technology Assessment
51
66
.
Helle Ploug Hansen & Jackie Street. 2017. Patient Involvement in Health Technology Assessment. Patient Involvement in Health Technology Assessment
31
42
.
Sally Wortley, Jackie Street, Wendy Lipworth & Kirsten Howard. (2016) What factors determine the choice of public engagement undertaken by health technology assessment decision-making organizations?. Journal of Health Organization and Management 30:6, pages 872-890.
Crossref
Crossref
Axel C. Mühlbacher, Christin Juhnke, Andrea R. Beyer & Sarah Garner. (2016) Patient-Focused Benefit-Risk Analysis to Inform Regulatory Decisions: The European Union Perspective. Value in Health 19:6, pages 734-740.
Crossref
Crossref
Edilene Lopes, Jackie Street, Drew Carter & Tracy Merlin. (2016) Involving patients in health technology funding decisions: stakeholder perspectives on processes used in Australia. Health Expectations 19:2, pages 331-344.
Crossref
Crossref
Hillegonda Maria Dutilh Novaes & Patrícia Coelho de Soárez. (2016) Health technology assessment (HTA) organizations: dimensions of the institutional and political framework. Cadernos de Saúde Pública 32:suppl 2.
Crossref
Crossref
Sally Wortley, Allison Tong & Kirsten Howard. (2016) Preferences for engagement in health technology assessment decision-making: a nominal group technique with members of the public. BMJ Open 6:2, pages e010265.
Crossref
Crossref
Julia Abelson, Frank Wagner, Deirdre DeJean, Sarah Boesveld, Franςois-Pierre Gauvin, Sally Bean, Renata Axler, Stephen Petersen, Shamara Baidoobonso, Gaylene Pron, Mita Giacomini & John Lavis. (2016) PUBLIC AND PATIENT INVOLVEMENT IN HEALTH TECHNOLOGY ASSESSMENT: A FRAMEWORK FOR ACTION. International Journal of Technology Assessment in Health Care 32:4, pages 256-264.
Crossref
Crossref
Axel C. Mühlbacher & Christin Juhnke. (2016) Patienten- und Bürgerpartizipation in der Entscheidungsfindung im Gesundheitswesen insbesondere bei der Bewertung von Arzneimitteln. Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen 110-111, pages 36-44.
Crossref
Crossref
Sally Wortley, Allison Tong, Emily Lancsar, Glenn Salkeld & Kirsten Howard. (2015) Public preferences for engagement in Health Technology Assessment decision-making: protocol of a mixed methods study. BMC Medical Informatics and Decision Making 15:1.
Crossref
Crossref
Jennifer A Whitty, Julie Ratcliffe, Elizabeth Kendall, Paul Burton, Andrew Wilson, Peter Littlejohns, Paul Harris, Rachael Krinks & Paul A Scuffham. (2015) Prioritising patients for bariatric surgery: building public preferences from a discrete choice experiment into public policy. BMJ Open 5:10, pages e008919.
Crossref
Crossref
Jessica Pace, Sallie-Anne Pearson & Wendy Lipworth. (2015) Improving the Legitimacy of Medicines Funding Decisions: A Critical Literature Review. Therapeutic Innovation & Regulatory Science 49:3, pages 364-368.
Crossref
Crossref
Mylène Tantchou Dipankui, Marie-Pierre Gagnon, Marie Desmartis, France Légaré, Florence Piron, Johanne Gagnon, Marc Rhiands & Martin Coulombe. (2015) EVALUATION OF PATIENT INVOLVEMENT IN A HEALTH TECHNOLOGY ASSESSMENT. International Journal of Technology Assessment in Health Care 31:3, pages 166-170.
Crossref
Crossref
Pooria Sarrami-Foroushani, Joanne Travaglia, Deborah Debono & Jeffrey Braithwaite. (2014) Implementing strategies in consumer and community engagement in health care: results of a large-scale, scoping meta-review. BMC Health Services Research 14:1.
Crossref
Crossref
Marie-Pierre Gagnon, Bernard Candas, Marie Desmartis, Johanne Gagnon, Daniel La Roche, Marc Rhainds, Martin Coulombe, Mylène Tantchou Dipankui & France Légaré. (2014) Involving patient in the early stages of health technology assessment (HTA): a study protocol. BMC Health Services Research 14:1.
Crossref
Crossref
Pooria Sarrami-Foroushani, Joanne Travaglia, Deborah Debono & Jeffrey Braithwaite. (2014) Key concepts in consumer and community engagement: a scoping meta-review. BMC Health Services Research 14:1.
Crossref
Crossref
Dean A. Regier, Colene Bentley, Craig Mitton, Stirling Bryan, Michael M. Burgess, Ellen Chesney, Andy Coldman, Jennifer Gibson, Jeffrey Hoch, Syed Rahman, Mona Sabharwal, Carol Sawka, Victoria Schuckel & Stuart J. Peacock. (2014) Public engagement in priority-setting: Results from a pan-Canadian survey of decision-makers in cancer control. Social Science & Medicine 122, pages 130-139.
Crossref
Crossref
Tania Stafinski & Devidas Menon. (2014) Transparency in Reimbursement Decisions: In Whose Best Interest?. PharmacoEconomics 32:8, pages 725-727.
Crossref
Crossref
Mylène Tantchou Dipankui, Marie-Pierre Gagnon, Marie Desmartis, France Legaré, Florence Piron, Johanne Gagnon, Marc Rhainds & Martin Coulombe. (2014) La participation des patients à l'évaluation des mesures alternatives à la contention et à l'isolement. Santé Publique Vol. 26:2, pages 217-226.
Crossref
Crossref
Barbara Piškur, Ramon Daniëls, Marian J Jongmans, Marjolijn Ketelaar, Rob JEM Smeets, Meghan Norton & Anna JHM Beurskens. (2013) Participation and social participation: are they distinct concepts?. Clinical Rehabilitation 28:3, pages 211-220.
Crossref
Crossref
Katharina E. FischerBjörn StollenwerkWolf H. Rogowski. (2013) Link between Process and Appraisal in Coverage Decisions. Medical Decision Making 33:8, pages 1009-1025.
Crossref
Crossref
Katharina E. Fischer, Wolf H. Rogowski, Reiner Leidl & Björn Stollenwerk. (2013) Transparency vs. closed-door policy: Do process characteristics have an impact on the outcomes of coverage decisions? A statistical analysis. Health Policy 112:3, pages 187-196.
Crossref
Crossref
David Hailey, Sophie Werkö, Rugayah Bakri, Alun Cameron, Britta Göhlen, Susan Myles, Jasmine Pwu & Jomkwan Yothasamut. (2012) INVOLVEMENT OF CONSUMERS IN HEALTH TECHNOLOGY ASSESSMENT ACTIVITIES BY INAHTA AGENCIES. International Journal of Technology Assessment in Health Care 29:1, pages 79-83.
Crossref
Crossref
Michael Drummond, Rosanna Tarricone & Aleksandra Torbica. (2013) Assessing the Added Value of Health Technologies: Reconciling Different Perspectives. Value in Health 16:1, pages S7-S13.
Crossref
Crossref
Jennifer A. Whitty. (2013) An International Survey of the Public Engagement Practices of Health Technology Assessment Organizations. Value in Health 16:1, pages 155-163.
Crossref
Crossref
Monique F Fournier. (2012) Knowledge mobilization in the context of health technology assessment: an exploratory case study. Health Research Policy and Systems 10:1.
Crossref
Crossref
Katharina E Fischer. (2012) Decision-making in healthcare: a practical application of partial least square path modelling to coverage of newborn screening programmes. BMC Medical Informatics and Decision Making 12:1.
Crossref
Crossref
Katharina Elisabeth Fischer. (2012) A systematic review of coverage decision-making on health technologies—Evidence from the real world. Health Policy 107:2-3, pages 218-230.
Crossref
Crossref
Josie Messina & David. L. Grainger. (2012) A Pilot Study to Identify Areas for Further Improvements in Patient and Public Involvement in Health Technology Assessments for Medicines. The Patient: Patient-Centered Outcomes Research 5:3, pages 199-211.
Crossref
Crossref
Josie Messina & David L. Grainger. (2012) A Pilot Study to Identify Areas for Further Improvements in Patient and Public Involvement in Health Technology Assessments for Medicines. The Patient - Patient-Centered Outcomes Research 5:3, pages 199-211.
Crossref
Crossref
Paule Poulin, Lea Austen, John B. Kortbeek & René Lafrenière. (2011) New Technologies and Surgical Innovation. Surgical Innovation 19:2, pages 187-199.
Crossref
Crossref
Katharina E. Fischer, Scott D. Grosse & Wolf H. Rogowski. (2011) The role of health technology assessment in coverage decisions on newborn screening. International Journal of Technology Assessment in Health Care 27:4, pages 313-321.
Crossref
Crossref